Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
2.800
+0.060 (2.19%)
At close: Dec 31, 2025, 4:00 PM EST
2.801
+0.001 (0.05%)
After-hours: Dec 31, 2025, 7:28 PM EST
Owens & Minor Market Cap
Owens & Minor has a market cap or net worth of $216.44 million as of December 31, 2025. Its market cap has decreased by -79.86% in one year.
Market Cap
216.44M
Enterprise Value
2.43B
1-Year Change
-79.86%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since December 1, 1998, Owens & Minor's market cap has decreased from $545.50M to $216.44M, a decrease of -60.32%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 216.60M | -78.51% |
| Dec 31, 2024 | 1.01B | -31.64% |
| Dec 29, 2023 | 1.47B | -0.99% |
| Dec 30, 2022 | 1.49B | -54.64% |
| Dec 31, 2021 | 3.28B | 65.06% |
| Dec 31, 2020 | 1.99B | 512.03% |
| Dec 31, 2019 | 324.90M | -17.58% |
| Dec 31, 2018 | 394.20M | -65.91% |
| Dec 29, 2017 | 1.16B | -46.73% |
| Dec 30, 2016 | 2.17B | -4.06% |
| Dec 31, 2015 | 2.26B | 2.16% |
| Dec 31, 2014 | 2.21B | -4.03% |
| Dec 31, 2013 | 2.31B | 27.67% |
| Dec 31, 2012 | 1.81B | 2.54% |
| Dec 30, 2011 | 1.76B | -5.43% |
| Dec 31, 2010 | 1.86B | 3.71% |
| Dec 31, 2009 | 1.80B | 15.37% |
| Dec 31, 2008 | 1.56B | -10.09% |
| Dec 31, 2007 | 1.73B | 37.84% |
| Dec 29, 2006 | 1.26B | 14.42% |
| Dec 30, 2005 | 1.10B | -1.08% |
| Dec 31, 2004 | 1.11B | 30.09% |
| Dec 31, 2003 | 853.70M | 52.42% |
| Dec 31, 2002 | 560.10M | -10.60% |
| Dec 31, 2001 | 626.50M | 6.66% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |